Skip to main content
SpringerLink
Log in

Leflunomide: Is It the Game Changer in Musculoskeletal Chronic Graft Versus Host Disease?

  • Correspondence
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Blazar BR, Murphy WJ, Abedi M (2012) Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 12:443–458

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Olivieri A, Locatelli F, Zecca M, Sanna A, Cimminiello M, Raimondi R et al (2009) Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 114:709–718

    Article  PubMed  CAS  Google Scholar 

  3. Breedveld FC, Dayer JM (2000) Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis 59:841–849

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Schorlemmer HU, Bartlett RR, Kurrle R (1997) Analogues of leflunomide’s primary metabolite, the malononitrilamides, prevent the development of graft-versus-host disease. Transpl Proc 29:1298–1301

    Article  CAS  Google Scholar 

  5. Mrowka C, Thoenes GH, Langer KH, Bartlett RR (1994) Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide. Ann Hematol 68:195–199

    Article  PubMed  CAS  Google Scholar 

  6. Déage V, Burger D, Dayer JM (1998) Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1beta and metalloproteinases. Eur Cytokine Netw 9:663–668

    PubMed  Google Scholar 

  7. Bartlett RR, Anagnostopulos H, Zielinski T, Mattar T, Schleyerbach R (1993) Effects of leflunomide on immune responses and models of inflammation. Springer Semin Immunopathol 14:381–394

    Article  PubMed  CAS  Google Scholar 

  8. Siemasko KF, Chong AS, Williams JW, Bremer EG, Finnegan A (1996) Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation 61:635–642

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. HSCT Unit, Department of Medical Oncology, ACTREC, Tata Memorial Centre, Room No. 247, Paymaster Shodhika, Kharghar, Navi Mumbai, 410210, India

    Kalasekhar Vijaysekharan, Sachin Punatar, Avinash Bonda, Aniket Mohite, Kartthik Shanmugam, Lingaraj Nayak, Anant Gokarn & Navin Khattry

Authors
  1. Kalasekhar Vijaysekharan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sachin Punatar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Avinash Bonda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aniket Mohite
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kartthik Shanmugam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lingaraj Nayak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anant Gokarn
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Navin Khattry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Navin Khattry.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research Involving Human Participants

This is not a clinical trial or research project. This is a case report highlighting the use of a drug routinely used in rheumatoid arthritis (an autoimmune disorder). The patient was treated at the discretion of the treating clinician.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vijaysekharan, K., Punatar, S., Bonda, A. et al. Leflunomide: Is It the Game Changer in Musculoskeletal Chronic Graft Versus Host Disease?. Indian J Hematol Blood Transfus 34, 566–567 (2018). https://doi.org/10.1007/s12288-018-0929-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-018-0929-x

Keywords

Search

Navigation